Aligos Therapeutics Presents Positive Data at the EASL Congress 2025

Stock Information for Aligos Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Aligos Therapeutics Inc.

Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aligos Therapeutics to Present at the Jefferies Global Healthcare Conference
Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
Aligos Therapeutics to Announce 1st Quarter 2025 Financial Results on May 6, 2025
Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.